NASDAQ:VLNS Valens (VLNS) Stock Price, News & Analysis → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free VLNS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.76▼$0.7650-Day Range$0.64▼$0.8152-Week Range$0.58▼$3.00VolumeN/AAverage Volume221,089 shsMarket Capitalization$61.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Valens alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Valens Stock (NASDAQ:VLNS)The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space. The company is headquartered in Toronto, Canada.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. VLNS Stock News HeadlinesMay 15, 2023 | proactiveinvestors.comSNDL targets $30M in synergies from 1Q Valens acquisition by the end of 2024April 2, 2023 | theglobeandmail.comClosing Bell: The Valens Company Inc. down on Wednesday (VLNS)April 27, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.March 4, 2023 | benzinga.comValens Semiconductor Stock (NYSE:VLN), Quotes and News SummaryJanuary 17, 2023 | proactiveinvestors.comThe Valens Company acquisition wrapped up by Canada's largest private liquor and cannabis retailer SNDLJanuary 17, 2023 | msn.comCannabis Giant SNDL Grows Bigger: Finalizes Valens Acquisition Becoming 'A Leader And Trusted Partner' In Canadian Marijuana SpaceJanuary 4, 2023 | benzinga.comValens Obtains Final Court Order Approving Merger With SNDLJanuary 3, 2023 | msn.comWhy SNDL Stock Flew as High as 5% on TuesdayApril 27, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.December 14, 2022 | markets.businessinsider.comWill Valens Remain On Nasdaq? It Has 180 Days to Regain Compliance With Minimum Bid Price Rule On This Stock ExchangeDecember 13, 2022 | finance.yahoo.comThe Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price RuleNovember 30, 2022 | proactiveinvestors.comThe Valens Company says shareholders overwhelmingly vote in favour of takeover by SNDLNovember 30, 2022 | benzinga.comValens Shareholders Approve The Arrangement With SNDLNovember 29, 2022 | prnewswire.comValens Shareholders Vote in Favour of the Arrangement with SNDLNovember 22, 2022 | finance.yahoo.comBOTH LEADING INDEPENDENT PROXY ADVISORS RECOMMEND SHAREHOLDERS OF THE VALENS COMPANY INC. VOTE FOR THE PROPOSED ARRANGEMENT WITH SNDL INC.November 3, 2022 | msn.comValens Secures License To Sell Micro Processed Cannabis Products From Its Pommies Beverage FacilityNovember 3, 2022 | proactiveinvestors.comThe Valens Company receives sales licence amendment from Health Canada for its Pommies manufacturing facilityNovember 2, 2022 | finance.yahoo.comValens Secures Sales Licence for Greater Toronto Area Beverage FacilityOctober 28, 2022 | msn.comThe Valens Announces Mailing And Filing Of Circular For Special Meeting Of Shareholders To Approve Arrangement With SNDLOctober 27, 2022 | finance.yahoo.comTHE VALENS COMPANY ANNOUNCES MAILING AND FILING OF CIRCULAR FOR SPECIAL MEETING OF SHAREHOLDERS TO APPROVE ARRANGEMENT WITH SNDL INC.October 15, 2022 | proactiveinvestors.comStifel GMP analysts repeat ‘Buy’ rating and C$1.20 price target for The Valens Company on robust 3Q resultsOctober 13, 2022 | proactiveinvestors.comThe Valens Company reports higher 3Q adjusted gross profit as integration initiatives kick inOctober 13, 2022 | msn.comValens Shares Slightly Up On Declining Quarterly RevenueOctober 13, 2022 | finance.yahoo.comThe Valens Company Reports Third Quarter Fiscal 2022 Financial ResultsOctober 12, 2022 | seekingalpha.comThe Valens Q3 Earnings PreviewOctober 6, 2022 | finance.yahoo.comThe Valens Company to Release Financial Results for the Third Quarter of 2022August 30, 2022 | apnews.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of The Valens Company Inc. (Nasdaq - VLNS)See More Headlines Receive VLNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Valens and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End11/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolNASDAQ:VLNS CUSIPN/A CIK1859902 Webwww.thevalenscompany.com Phone778-755-0052FaxN/AEmployees445Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-39,110,000.00 Net Margins-274.38% Pretax MarginN/A Return on Equity-48.02% Return on Assets-29.74% Debt Debt-to-Equity Ratio0.80 Current Ratio2.08 Quick Ratio1.49 Sales & Book Value Annual Sales$62.37 million Price / Sales0.98 Cash FlowN/A Price / Cash FlowN/A Book Value$1.30 per share Price / Book0.58Miscellaneous Outstanding Shares80,740,000Free Float77,696,000Market Cap$61.38 million OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jeffrey Fallows C.F.A.L.L.B., M.B.A., CFA, PresMr. Sunil Gandhi CPAChief Financial OfficerMs. Chantel PopoffChief Operating OfficerMr. Adam SheaChief Commercial OfficerMr. Scott YoungHead of Investor RelationsMr. Everett Knight C.F.A.Exec. VP of Corp. Devel. & Capital MarketsMr. Anderson SmithHead of Regulatory AffairsMr. Daniel HowardVP, Bus. Devel.More ExecutivesKey CompetitorsNatural Alternatives InternationalNASDAQ:NAIIBright GreenNASDAQ:BGXXMannatechNASDAQ:MTEXFitLife BrandsNASDAQ:FTLFMediWoundNASDAQ:MDWDView All Competitors This page (NASDAQ:VLNS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Valens Company Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
